Milestones may or may not be reached. In mid-2006 Cytopia signed a $274 million licence deal with Novartis: http://www.theage.com.au/news/Business/Cytopia-274m-licence-deal-with-Novartis/2006/06/05/1149359651202.html At the beginning of 2010 Cytopia was taken over by a Canadian bioscience company, for a pittance - about $14m.
Phylogica is (I think) a reasonable speculative long-term play, but the $98 million from the Medimmune deal isn't even close to hatching.
positive results to roche, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $3.22K | 30.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 1337560 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 683909 | 10 |
View Market Depth
| Last trade - 10.27am 26/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |